Evidence map›Paper›PMID 40979385›Full record

ArticleFrontiers in drug safety and regulation2024

Measurement error and bias in real-world oncology endpoints when constructing external control arms.

Benjamin Ackerman, Ryan W Gan, Craig S Meyer, Jocelyn R Wang, Youyi Zhang, Jennifer Hayden, Grace Mahoney, Jennifer L Lund, Janick Weberpals, Sebastian Schneeweiss and 8 more

Abstract read
In one paragraph

Article in Frontiers in drug safety and regulation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Benjamin AckermanJanssen Research and Development, LLC, A Johnson and Johnson Company, Raritan, NJ, United States.
Ryan W GanJanssen Research and Development, LLC, A Johnson and Johnson Company, Raritan, NJ, United States.
Craig S MeyerJanssen Research and Development, LLC, A Johnson and Johnson Company, Raritan, NJ, United States.
Jocelyn R WangJanssen Research and Development, LLC, A Johnson and Johnson Company, Raritan, NJ, United States.
Youyi ZhangJanssen Research and Development, LLC, A Johnson and Johnson Company, Raritan, NJ, United States.
Jennifer HaydenJanssen Research and Development, LLC, A Johnson and Johnson Company, Raritan, NJ, United States.
Grace MahoneyJanssen Research and Development, LLC, A Johnson and Johnson Company, Raritan, NJ, United States.
Jennifer L LundDepartment of Epidemiology, University of North Carolina, Chapel Hill, United States.
Janick WeberpalsDivision of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Harvard Medical School, Boston, United States.
Sebastian SchneeweissDivision of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Harvard Medical School, Boston, United States.
James RooseFlatiron Health, New York, NY, United States.
Juned SiddiquePreventive Medicine and Psychiatry and Behavioral Science, Feinberg School of Medicine, Northwestern University, Chicago, United States.
Omar NadeemDepartment of Hematology and Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, United States.
Smith GiriDivision of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, United States.
Til StürmerDepartment of Epidemiology, University of North Carolina, Chapel Hill, United States.
Sikander AilawadhiDepartment of Hematology, Mayo Clinic, Jacksonville, United States.
Ashita S Batavia *Janssen Research and Development, LLC, A Johnson and Johnson Company, Raritan, NJ, United States.
Khaled Sarsour *Janssen Research and Development, LLC, A Johnson and Johnson Company, Raritan, NJ, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

endpointsexternal control armmeasurement errormisclassification biasoncologyprogression-free survivalreal-world data (RWD)surveillance bias

Identifiers

PMID40979385
PMCPMC12443075

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.